SCHEMBL4455007

SCHEMBL4455007

[CH2]CC=CCC(C)CC(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4455005 1.00
SCHEMBL1190830 0.78
SCHEMBL1190832 0.78
SCHEMBL2121145 0.77
SCHEMBL2121141 0.77
SCHEMBL11503170 0.77 GRIK1 (0.35)
SCHEMBL7161989 0.75
SCHEMBL7161990 0.75
SCHEMBL2118367 0.73 TSHR (0.39)
SCHEMBL2118368 0.73 TSHR (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090317476-A1 COMBINATION OF DEHYDROEPIANDROSTERONE OR DEHYDROEPIANDROSTERONE-SULFATE WITH A LEUKOTRIENE RECEPTOR ANTAGONIST FOR TREATMENT OF ASTHMA OR CHRONIC OBSTRUCTIVE PULMONARY DISEASE EPIGENESIS PHARMACEUTICALS, LLC 2009-12-24 US disclosed
EP-1653910-A2 COMBINATION OF DEHYDROEPIANDROSTERONE OR DEHYDROEPIANDROSTERONE-SULFATE WITH A LEUKOTRIENE RECEPTOR ANTAGONIST FOR TREATMENT OF ASTHMA OR CHRONIC OBSTRUCTIVE PULMONARY DISEASE Epigenesis Pharmaceuticals LLC (US) 2006-05-10 EP disclosed
US-20050101544-A1 Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a leukotriene receptor antagonist for treatment of asthma or chronic obstructive pulmonary disease EPIGENESIS PHARMACEUTICALS, LLC 2005-05-12 US disclosed
WO-2005011595-A2 COMBINATION OF DEHYDROEPIANDROSTERONE OR DEHYDROEPIANDROSTERONE-SULFATE WITH A LEUKOTRIENE RECEPTOR ANTAGONIST FOR TREATMENT OF ASTHMA OR CHRONIC OBSTRUCTIVE PULMONARY DISEASE EPIGENESIS PHARMACEUTICALS LLC (US) 2005-02-10 WO disclosed
US-20050026882-A1 Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a leukotriene receptor antagonist for treatment of asthma or chronic obstructive pulmonary disease EPIGENESIS PHARMACEUTICALS LLC 2005-02-03 US disclosed
US-5446058-A Leukotriene antagonists, 5-alpha-reductase inhibitors ONO PHARMACEUTICAL CO., LTD. (JP) 1995-08-29 US disclosed
EP-0463638-B1 Aminophenyl derivatives ONO PHARMACEUTICAL CO (JP) 1995-05-24 EP disclosed
EP-0173516-B1 (Fused)benz(thio)amides ONO PHARMACEUTICAL CO (JP) 1993-12-01 EP disclosed
EP-0463638-A1 Aminophenyl derivatives ONO PHARMACEUTICAL CO., LTD. (JP) 1992-01-02 EP disclosed
US-4939141-A (Fused) benz (thio) amides and pharmaceutical compositions, thereof ONO PHARMACEUTICAL CO., LTD. (JP) 1990-07-03 US disclosed
US-4847275-A ENZYME INHIBITOR, LEUKOTRIENE ANTAGONIST ONO PHARMACEUTICAL CO., LTD. (JP) 1989-07-11 US disclosed
US-4780469-A (Fused) benz(thio)amides and pharmaceutical use ONO PHARMACEUTICAL CO., LTD. (JP) 1988-10-25 US disclosed
EP-0173516-A2 (Fused)benz(thio)amides ONO PHARMACEUTICAL CO., LTD. (JP) 1986-03-05 EP disclosed